Relentless in her pursuit of innovation, Delphine is a firm believer that the future of medical communication lies in relevant and memorable engagement with HCPs, which will truly make a difference for patients worldwide. Through her 20 years of experience, she has perfected the ability to build strategic road maps for new and existing brands and to create immersive storytelling experiences, based on smart, competent solutions, which truly create medical education that sticks.
Before becoming involved with medical education, Delphine was a general practitioner in Paris. She received her MD from the University of Paris, Faculté de Médecine Saint-Antoine, and an MBA from the Ecole Supérieure de Commerce de Paris, where she currently teaches global launches and multichannel planning.
Despite her successful career in the US, she will never give up French wine, bread, and celebrating Bastille Day.
Guided by Jan-Willem, HSC's purpose-built teams have demonstrated a unique ability to help their clients translate the science of their products and the pathogenesis of associated diseases into clinically relevant and scientifically accurate information understandable by the target audience. Translation of the science is the basis of a scientific platform and development of a scientific brand and is crucial to successful new product launches and life-cycle management. With a medical degree as well as PhD in medicine and an MBA from NYU’s Stern School of Business, Jan-Willem has a deep understanding not only of the scientific side of the business, but also the business side of the science. This helps him take a holistic approach to issues, weighing the viewpoints of all stakeholders and their importance to create a complete picture and develop the best client solutions in a rapidly changing environment.
Jan-Willem regularly travels back to his home country, the Netherlands, to visit family, buy Dutch cheese and licorice, and watch his favorite sport, field hockey.
A CPA by training, Michael Weems has worked in the medical education and communications industry for over 20 years. He has been with Health Science Communications New Jersey since 2003, when he joined the company as VP, Finance, and helped lead and integrate their merger with Omnicom Group and HCG. In his current position as HCG US CFO, he is responsible for overseeing the financial operations, reporting and contracting of HCG US. While with Health Science Communications New Jersey, Michael has been involved in strategic planning, advocacy development, competitive intelligence, publications and other medical education initiatives in support of several products.
After earning his bachelor of arts degree in accounting from Rutgers University in Newark, New Jersey, Michael worked for Coopers & Lybrand in New York City, where he was a senior accountant and financial analyst performing audit work and internal analysis. Michael left Coopers & Lybrand for Churchill/Quadrant Publications in Chatham, New Jersey, where he was promoted from controller to vice president of finance. Prior to joining Health Science Communications New Jersey, he was vice president of finance and operations at Ingenix Medical Education in Basking Ridge, New Jersey.
Dr. Predich's experience in cardiology encompasses therapies for heart failure, pulmonary arterial hypertension, hypertension, arrhythmias, deep vein thrombosis/pulmonary embolism, stroke prevention in atrial fibrillation, acute coronary syndromes, peripheral arterial disease, and percutaneous coronary intervention.
Scientific communications developed or supervised by Dr. Predich have been addressed to a wide variety of audiences, including specialist and primary care physicians, pharmacists, and nurses.
Dr. Predich has led the development of numerous scientific communication projects for various cardiovascular products, including Natrecor (nesiritide), omecamtiv mecarbil, Samsca (tolvaptan), Orenitram (treprostinil), ralinepag, nebivolol, Brinavess (vernakalant), Xarelto (rivaroxaban), Savaysa (edoxaban), Integrilin (eptifibatide), Lovenox (enoxaparin sodium injection), Plavix (clopidogrel), Zontivity (vorapaxar), and Cypher (sirolimus-eluting coronary stent).
Dr. Predich received his PhD in microbiology from NYU Medical School.
Postdoctoral fellowships at the Public Health Research Institute and Rockefeller University
Contributing editor of the scientific journal Nature Biotechnology
Projects included scientific platforms, mechanism of disease and mechanism of action illustrations and animations, disease awareness slide presentations, product slide presentations, and speaker training programs
With over 20 years of experience in the healthcare communications industry, Fariba brings a wealth of scientific and marketing acumen to her role as Executive Vice President, Client Services, at HSC-NJ. She has been involved in many aspects of the industry: from operations, to business development, to strategic account planning and implementation. She has managed both scientific and client services teams.
Fariba has broad experience in medical education (promotional and medical affairs), opinion leader engagement, strategic publications planning, and training programs across a wide range of therapeutic areas in support of prelaunch, launch and life-cycle management for many brands.
Fariba graduated from Clarkson University in Potsdam, New York, and received her PhD in medicinal chemistry from Rutgers University in Piscataway, New Jersey. She has authored or co-authored several articles for peer-reviewed publications, such as Drug Design and Discovery.
Nikolay’s master’s degree in journalism is a bit odd, considering his natural love for the sciences. This love most likely comes from the fact that in science, just like in advertising, you never run out of options for what to do. It’s like a never-ending puzzle that you can continue to solve, and it gets more exciting over time. An award-winning creative, Nikolay gained valuable experience working for some of the world’s largest brands, at a variety of big international agencies and small independent shops, both from within and outside the pharma world. He prides himself in finding the simplest, most elegant, and beautiful solution to a problem without losing track of the main idea. He has extended experience in multiple disease awareness initiatives, including large conference and symposia tactics, ranging from traditional to the cutting edge of innovation. Always striving for creative excellence and constantly looking for what’s next, Nikolay makes sure all work meets his elevated creative standards, is innovative, and “speaks” high-level science.
Jennifer has forged a strong reputation for strategic launch planning, seamless collaboration, and executional excellence throughout her career. She started her medical communications career in the speaker’s bureau, and has worked in all aspects of the business, including promotional medical education, CME, peer-to-peer programs, medical affairs, and KOL engagement. Jennifer is devoted to pulling through the scientific strategy to achieve her clients’ goals.
Jennifer’s dedication to client satisfaction has ensured that she remains a longtime asset to her clients. Among some of her successes are working on over 15 launches worldwide, creating early communication for biotech products, managing multiple brands in large franchises, planning for LOE, and working collaboratively on consolidated agency models.
When she is not working, Jennifer enjoys life through some of her hobbies, which include skiing, hiking, traveling, and scuba diving.
